The clinical outcomes are complex and often involve multiple systems. Early identification and standardization are critical to improving prognosis. The diagnosis of the disease requires a combination of clinical outcomes, imaging inspections, laboratory tests and pathological evaluations.
The platform can assist in linking teams of authoritative experts at home and abroad to provide accurate diagnostics and treatment programs. Treatment and management of HPE requires multi-dimensional development, typically including drug therapy, rehabilitation interventions, regular follow-up, and so on. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult-to-treat genetic metabolic diseases have been significantly improved.
Treatment requires close monitoring of therapeutic effects and adverse reactions and timely adjustment to changes in the course of the disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of HPE. The platform serves a team of domestic and foreign experts in the field of genetic metabolism in China.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.